Neville Rodie & Shaw Inc. decreased its position in Colgate-Palmolive Company (NYSE:CL) by 3.9% during the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 26,095 shares of the company’s stock after selling 1,050 shares during the period. Neville Rodie & Shaw Inc.’s holdings in Colgate-Palmolive were worth $1,910,000 at the end of the most recent reporting period.
Several other institutional investors also recently modified their holdings of the company. Thrivent Financial for Lutherans raised its position in shares of Colgate-Palmolive by 5.9% in the fourth quarter. Thrivent Financial for Lutherans now owns 30,960 shares of the company’s stock worth $2,026,000 after buying an additional 1,730 shares in the last quarter. IFM Investors Pty Ltd bought a new position in shares of Colgate-Palmolive during the fourth quarter worth $706,000. Heritage Way Advisors LLC acquired a new stake in Colgate-Palmolive during the fourth quarter worth about $1,736,000. Archford Capital Strategies LLC increased its stake in Colgate-Palmolive by 4.8% in the fourth quarter. Archford Capital Strategies LLC now owns 9,530 shares of the company’s stock worth $623,000 after buying an additional 439 shares during the last quarter. Finally, Independent Advisor Alliance acquired a new stake in Colgate-Palmolive during the fourth quarter worth about $1,597,000. Hedge funds and other institutional investors own 73.69% of the company’s stock.
Colgate-Palmolive Company (NYSE CL) traded down 0.39% on Friday, reaching $71.02. 3,317,565 shares of the company traded hands. The stock has a market capitalization of $62.56 billion, a price-to-earnings ratio of 26.39 and a beta of 0.80. Colgate-Palmolive Company has a 1-year low of $63.43 and a 1-year high of $77.27. The stock has a 50 day moving average of $72.30 and a 200-day moving average of $72.91.
Colgate-Palmolive (NYSE:CL) last announced its quarterly earnings results on Friday, July 21st. The company reported $0.72 earnings per share for the quarter, meeting the consensus estimate of $0.72. The firm had revenue of $3.83 billion for the quarter, compared to analysts’ expectations of $3.89 billion. Colgate-Palmolive had a net margin of 15.83% and a return on equity of 3,121.95%. The company’s revenue was down .5% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.70 EPS. On average, equities analysts anticipate that Colgate-Palmolive Company will post $2.89 EPS for the current year.
The company also recently declared a quarterly dividend, which was paid on Tuesday, August 15th. Stockholders of record on Tuesday, July 18th were given a dividend of $0.40 per share. The ex-dividend date was Friday, July 14th. This represents a $1.60 annualized dividend and a dividend yield of 2.25%. Colgate-Palmolive’s payout ratio is 59.48%.
ILLEGAL ACTIVITY NOTICE: This report was first published by BNB Daily and is the property of of BNB Daily. If you are viewing this report on another domain, it was illegally copied and reposted in violation of United States & international copyright legislation. The legal version of this report can be viewed at https://www.baseball-news-blog.com/2017/08/19/colgate-palmolive-company-nysecl-shares-sold-by-neville-rodie-shaw-inc-updated-updated-updated.html.
A number of equities research analysts recently issued reports on CL shares. Bank of America Corporation upped their price target on shares of Colgate-Palmolive from $78.00 to $80.00 and gave the company a “buy” rating in a research note on Wednesday, May 31st. Zacks Investment Research downgraded shares of Colgate-Palmolive from a “hold” rating to a “sell” rating in a research note on Thursday, July 27th. Vetr downgraded shares of Colgate-Palmolive from a “buy” rating to a “hold” rating and set a $76.67 price target on the stock. in a research note on Wednesday, May 17th. Royal Bank Of Canada reaffirmed a “hold” rating and set a $74.00 price target on shares of Colgate-Palmolive in a research note on Thursday, May 25th. Finally, Jefferies Group LLC reaffirmed a “hold” rating and set a $76.00 price target on shares of Colgate-Palmolive in a research note on Wednesday, May 17th. Two investment analysts have rated the stock with a sell rating, twelve have given a hold rating and two have assigned a buy rating to the company’s stock. The stock presently has a consensus rating of “Hold” and an average target price of $75.82.
In related news, insider Patricia Verduin sold 3,833 shares of the business’s stock in a transaction dated Thursday, June 15th. The shares were sold at an average price of $75.67, for a total value of $290,043.11. Following the sale, the insider now directly owns 53,022 shares in the company, valued at approximately $4,012,174.74. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, Director Ellen M. Hancock sold 5,057 shares of the business’s stock in a transaction dated Tuesday, August 1st. The shares were sold at an average price of $71.91, for a total transaction of $363,648.87. Following the completion of the sale, the director now owns 199,777 shares in the company, valued at $14,365,964.07. The disclosure for this sale can be found here. In the last three months, insiders have sold 221,802 shares of company stock worth $15,983,976. Corporate insiders own 1.02% of the company’s stock.
Colgate-Palmolive Company (Colgate) is a consumer products company. The Company operates in two product segments: Oral, Personal and Home Care, and Pet Nutrition. The Oral, Personal and Home Care product segment is operated through five geographic segments, which include North America, Latin America, Europe, Asia Pacific and Africa/Eurasia.
Receive News & Ratings for Colgate-Palmolive Company Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive Company and related companies with MarketBeat.com's FREE daily email newsletter.